IGF2R-Targeted Alpha Therapy of Osteosarcoma Enabled by Conjugated [ 225 Ac]Ac-Macropa-PEG 4 -IF3

View at publisher
Authors: Syed Qaiser Shah, Ralph Santos‐Oliveira, Derya Ilem-Ozdemir, Madeeha Shabnam
Cited by: 1
References: 34

Abstract

-IF3 is a translational orphan alpha therapeutic for osteosarcoma with excellent radiochemical stability and potency and low off-target toxicity.

Fields of Study & Subjects

Radiopharmaceutical Chemistry and Applications Cancer Hypoxia and Metabolism Neuroblastoma Research and Treatments

Publication details

Journal / source
Bioconjugate Chemistry
Publisher
American Chemical Society (ACS)
Volume
37
Issue
5
Pages
1025–1034
Publication date
7 May 2026
Language
EN